FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2164230684> ?p ?o ?g. }

• W2164230684 endingPage "8715" @default.
• W2164230684 startingPage "8703" @default.
• W2164230684 abstract "// Ayesha B. Alvero 1 , Michele K. Montagna 1 , Natalia J. Sumi 1 , Won Duk Joo 1 , Emma Graham 1 and Gil Mor 1 1 Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA Correspondence: Gil Mor, email: // Keywords : ovarian cancer, cancer stem cells, oxidative phosphorylation, Warburg effect, maintenance treatment Received : June 29, 2014 Accepted : August 18, 2014 Published : August 19, 2014 Abstract Survival rate in ovarian cancer has not improved since chemotherapy was introduced a few decades ago. The dismal prognosis is mostly due to disease recurrence where majority of the patients succumb to the disease. The demonstration that tumors are comprised of subfractions of cancer cells displaying heterogeneity in stemness potential, chemoresistance, and tumor repair capacity suggests that recurrence may be driven by the chemoresistant cancer stem cells. Thus to improve patient survival, novel therapies should eradicate this cancer cell population. We show that in contrast to the more differentiated ovarian cancer cells, the putative CD44+/MyD88+ ovarian cancer stem cells express lower levels of pyruvate dehydrogenase, Cox–I, Cox-II, and Cox–IV, and higher levels of UCP2. Together, this molecular phenotype establishes a bioenergetic profile that prefers the use of glycolysis over oxidative phosphorylation to generate ATP. This bioenergetic profile is conserved in vivo and therefore a maintenance regimen of 2-deoxyglucose administered after Paclitaxel treatment is able to delay the progression of recurrent tumors and decrease tumor burden in mice. Our findings strongly suggest the value of maintenance with glycolysis inhibitors with the goal of improving survival in ovarian cancer patients." @default.
• W2164230684 created "2016-06-24" @default.
• W2164230684 creator A5024198389 @default.
• W2164230684 creator A5047550774 @default.
• W2164230684 creator A5062173702 @default.
• W2164230684 creator A5064908500 @default.
• W2164230684 creator A5078106091 @default.
• W2164230684 creator A5088903979 @default.
• W2164230684 date "2014-08-19" @default.
• W2164230684 modified "2023-10-10" @default.
• W2164230684 title "Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors" @default.
• W2164230684 cites W1483212110 @default.
• W2164230684 cites W1965281877 @default.
• W2164230684 cites W1966932597 @default.
• W2164230684 cites W1982080917 @default.
• W2164230684 cites W1984314373 @default.
• W2164230684 cites W1992514491 @default.
• W2164230684 cites W2003263637 @default.
• W2164230684 cites W2010397777 @default.
• W2164230684 cites W2017751746 @default.
• W2164230684 cites W2019865561 @default.
• W2164230684 cites W2020024735 @default.
• W2164230684 cites W2024646477 @default.
• W2164230684 cites W2029436635 @default.
• W2164230684 cites W2036829369 @default.
• W2164230684 cites W2036927649 @default.
• W2164230684 cites W2037959202 @default.
• W2164230684 cites W2040777081 @default.
• W2164230684 cites W2042504292 @default.
• W2164230684 cites W2046741252 @default.
• W2164230684 cites W2055677253 @default.
• W2164230684 cites W2062069198 @default.
• W2164230684 cites W2063802627 @default.
• W2164230684 cites W2067625941 @default.
• W2164230684 cites W2072549244 @default.
• W2164230684 cites W2074059417 @default.
• W2164230684 cites W2075306556 @default.
• W2164230684 cites W2080097604 @default.
• W2164230684 cites W2086079357 @default.
• W2164230684 cites W2095945017 @default.
• W2164230684 cites W2100723703 @default.
• W2164230684 cites W2101799172 @default.
• W2164230684 cites W2102085111 @default.
• W2164230684 cites W2102322990 @default.
• W2164230684 cites W2110552916 @default.
• W2164230684 cites W2112499249 @default.
• W2164230684 cites W2130503287 @default.
• W2164230684 cites W2134987819 @default.
• W2164230684 cites W2135869338 @default.
• W2164230684 cites W2143219457 @default.
• W2164230684 cites W4243903519 @default.
• W2164230684 cites W94071839 @default.
• W2164230684 doi "https://doi.org/10.18632/oncotarget.2367" @default.
• W2164230684 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4226715" @default.
• W2164230684 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25237928" @default.
• W2164230684 hasPublicationYear "2014" @default.
• W2164230684 type Work @default.
• W2164230684 sameAs 2164230684 @default.
• W2164230684 citedByCount "25" @default.
• W2164230684 countsByYear W21642306842015 @default.
• W2164230684 countsByYear W21642306842016 @default.
• W2164230684 countsByYear W21642306842017 @default.
• W2164230684 countsByYear W21642306842018 @default.
• W2164230684 countsByYear W21642306842019 @default.
• W2164230684 countsByYear W21642306842020 @default.
• W2164230684 countsByYear W21642306842022 @default.
• W2164230684 countsByYear W21642306842023 @default.
• W2164230684 crossrefType "journal-article" @default.
• W2164230684 hasAuthorship W2164230684A5024198389 @default.
• W2164230684 hasAuthorship W2164230684A5047550774 @default.
• W2164230684 hasAuthorship W2164230684A5062173702 @default.
• W2164230684 hasAuthorship W2164230684A5064908500 @default.
• W2164230684 hasAuthorship W2164230684A5078106091 @default.
• W2164230684 hasAuthorship W2164230684A5088903979 @default.
• W2164230684 hasBestOaLocation W21642306841 @default.
• W2164230684 hasConcept C109156525 @default.
• W2164230684 hasConcept C121608353 @default.
• W2164230684 hasConcept C126322002 @default.
• W2164230684 hasConcept C143998085 @default.
• W2164230684 hasConcept C1491633281 @default.
• W2164230684 hasConcept C20251656 @default.
• W2164230684 hasConcept C2780427987 @default.
• W2164230684 hasConcept C2780932548 @default.
• W2164230684 hasConcept C28328180 @default.
• W2164230684 hasConcept C2908647359 @default.
• W2164230684 hasConcept C502942594 @default.
• W2164230684 hasConcept C55427017 @default.
• W2164230684 hasConcept C55493867 @default.
• W2164230684 hasConcept C62231903 @default.
• W2164230684 hasConcept C71924100 @default.
• W2164230684 hasConcept C86803240 @default.
• W2164230684 hasConcept C95444343 @default.
• W2164230684 hasConcept C96232424 @default.
• W2164230684 hasConcept C99454951 @default.
• W2164230684 hasConceptScore W2164230684C109156525 @default.
• W2164230684 hasConceptScore W2164230684C121608353 @default.
• W2164230684 hasConceptScore W2164230684C126322002 @default.
• W2164230684 hasConceptScore W2164230684C143998085 @default.

• next